MedXY
Not signed in Sign in / Register
Skip to content
medxy logo

Medxy AI

  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Under Venetoclax-Based First-Line Therapy
Posted inHematology-Oncology news

Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Under Venetoclax-Based First-Line Therapy

Posted by By MedXY 10/11/2026
Telomere length serves as an independent prognostic marker for progression-free survival in chronic lymphocytic leukemia patients treated with venetoclax-based regimens, highlighting its role in risk stratification during the modern targeted therapy era.
Read More
High Efficacy and Safety of Glofitamab Plus Polatuzumab-R-CHP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Multicenter Study
Posted inHematology-Oncology news Oncology

High Efficacy and Safety of Glofitamab Plus Polatuzumab-R-CHP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Multicenter Study

Posted by By MedXY 10/11/2026
A phase II trial shows that adding the bispecific antibody glofitamab to polatuzumab-R-CHP achieves a 95% complete response rate and durable remission with minimal cytokine release syndrome in high-risk diffuse large B-cell lymphoma.
Read More
Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia
Posted inHematology-Oncology news Oncology

Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia

Posted by By MedXY 10/11/2026
This article reviews the KOMET-007 trial evaluating ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated AML, highlighting promising remission rates and manageable safety.
Read More
Optimizing ICU Pharmacist Workload: Impact on Patient Mortality and Medication Management
Posted inCritical Care news

Optimizing ICU Pharmacist Workload: Impact on Patient Mortality and Medication Management

Posted by By MedXY 10/11/2026
This study identifies higher pharmacist-to-patient ratios and interruptions in comprehensive medication management as key contributors to increased mortality among ICU patients, highlighting the need for optimized pharmacist staffing in critical care.
Read More
Trajectory of Exacerbations in Biologic-Eligible Severe Asthma: Insights from UK Nationwide Data
Posted inAllergy & Immunology news Respiratory

Trajectory of Exacerbations in Biologic-Eligible Severe Asthma: Insights from UK Nationwide Data

Posted by By MedXY 10/11/2026
A large UK study reveals that over two-thirds of biologic-eligible severe asthma patients improve without biologic therapy, identifying distinct exacerbation trajectories linked to blood eosinophil levels and disease phenotype.
Read More
Sotatercept as Add-On Therapy in Pediatric Pulmonary Hypertension: Promising Outcomes from the Pediatric Pulmonary Hypertension Network
Posted inCardiology news Pediatrics

Sotatercept as Add-On Therapy in Pediatric Pulmonary Hypertension: Promising Outcomes from the Pediatric Pulmonary Hypertension Network

Posted by By MedXY 10/11/2026
Retrospective multi-center data demonstrate that sotatercept improves functional status, exercise capacity, and hemodynamics in children with pulmonary hypertension, with a manageable safety profile.
Read More
Lung Health after Preterm Birth: Practical Consensus for Lifelong Respiratory Care
Posted innews Pediatrics Respiratory

Lung Health after Preterm Birth: Practical Consensus for Lifelong Respiratory Care

Posted by By MedXY 10/11/2026
An expert consensus from the BPD Collaborative outlines pragmatic, lifespan-focused recommendations to identify, monitor, and manage prematurity-associated lung disease (PLD) and to standardize outpatient care from infancy through adulthood.
Read More
Gut Microbiota and Idiopathic Pulmonary Fibrosis: Associations with Disease Severity and Survival Outcomes
Posted inClinical Updates news Respiratory

Gut Microbiota and Idiopathic Pulmonary Fibrosis: Associations with Disease Severity and Survival Outcomes

Posted by By MedXY 10/11/2026
Emerging evidence reveals gut microbiota profiles correlate with disease severity and survival in idiopathic pulmonary fibrosis, highlighting potential microbial biomarkers and treatment modifiers.
Read More
Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis: Enhancing Diagnostic and Prognostic Precision
Posted innews Respiratory

Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary Fibrosis: Enhancing Diagnostic and Prognostic Precision

Posted by By MedXY 10/11/2026
Age-adjusted WGS-estimated telomere length improves identification of pathologically short telomeres and detection of telomere-related variants in IPF, associating with survival outcomes but offering limited survival prediction beyond clinical variables.
Read More
PCSK9 Inhibitors and Their Protective Role Against Retinal Vascular Occlusions in Hyperlipidemic Patients
Posted inCardiology news Ophthalmology

PCSK9 Inhibitors and Their Protective Role Against Retinal Vascular Occlusions in Hyperlipidemic Patients

Posted by By MedXY 10/11/2026
PCSK9 inhibitors significantly reduce the risk of retinal vascular occlusions compared to other lipid-lowering therapies in patients with hyperlipidemia, highlighting their potential as a neuroprotective cardiovascular intervention.
Read More
Advancing Gender Equity in Ophthalmology: The Impact of Virtual Oral Board Exams on Workforce Representation
Posted innews Ophthalmology

Advancing Gender Equity in Ophthalmology: The Impact of Virtual Oral Board Exams on Workforce Representation

Posted by By MedXY 10/11/2026
This study reveals a significant increase in female representation among American Board of Ophthalmology oral board examiners following the transition to virtual exams, while the proportion of female examinees remained stable from 2011 to 2024.
Read More
Individualized High-Fluence Corneal Cross-Linking for Ultrathin Keratoconus: Insights from the ELZA-sub400 Protocol
Posted innews Ophthalmology

Individualized High-Fluence Corneal Cross-Linking for Ultrathin Keratoconus: Insights from the ELZA-sub400 Protocol

Posted by By MedXY 10/11/2026
The ELZA-sub400 protocol demonstrates safe and effective high-fluence corneal cross-linking tailored for ultrathin keratoconus corneas, halting ectasia progression in most treated eyes at 12 months with no endothelial damage.
Read More
Presbylarynx and Laryngeal Asymmetry: Unreliable Predictors of Dysphonia in Older Adults
Posted innews Otorhinolaryngology

Presbylarynx and Laryngeal Asymmetry: Unreliable Predictors of Dysphonia in Older Adults

Posted by By MedXY 10/11/2026
This study assesses whether presbylarynx and laryngeal asymmetry observed on videostroboscopy predict voice complaints in adults over 65, finding no association despite common anatomical changes with aging.
Read More
Efficacy of Office-Based Blue Laser Therapy Combined with Steroid Injection for Hemorrhagic versus Nonhemorrhagic Vocal Fold Polyps
Posted innews Otorhinolaryngology

Efficacy of Office-Based Blue Laser Therapy Combined with Steroid Injection for Hemorrhagic versus Nonhemorrhagic Vocal Fold Polyps

Posted by By MedXY 10/11/2026
This study highlights that hemorrhagic vocal fold polyps show superior response to office-based blue laser therapy combined with intralesional steroid injection compared to nonhemorrhagic polyps, with higher rates of complete regression and improvements in voice outcomes.
Read More
Navigating Airway Management in Endolaryngeal Surgery: Comparing High-Flow Nasal Cannula and High-Frequency Jet Ventilation
Posted inAnesthesiology news Otorhinolaryngology

Navigating Airway Management in Endolaryngeal Surgery: Comparing High-Flow Nasal Cannula and High-Frequency Jet Ventilation

Posted by By MedXY 10/11/2026
This study evaluates High-Flow Nasal Cannula (HFNC) versus High-Frequency Jet Ventilation (HFJV) during endolaryngeal surgery, highlighting HFJV's superiority in sustaining oxygenation and avoiding hypercapnia over longer durations.
Read More
Evaluating the Impact of a Virtual Tobacco Cessation Program in Surgical Patients: Challenges and Insights
Posted inGeneral Surgery news Public Health

Evaluating the Impact of a Virtual Tobacco Cessation Program in Surgical Patients: Challenges and Insights

Posted by By MedXY 10/11/2026
A virtual tobacco cessation program targeting surgical patients showed low engagement despite potential benefits, highlighting the need for tailored approaches to improve participation and outcomes in this population.
Read More
Evaluating Early Palliative Care Impact on End-of-Life Outcomes in Surgical Cancer Patients: Insights from the SOPE Trial
Posted inGeneral Surgery news Oncology

Evaluating Early Palliative Care Impact on End-of-Life Outcomes in Surgical Cancer Patients: Insights from the SOPE Trial

Posted by By MedXY 10/11/2026
A randomized trial found no significant benefit of early specialist palliative care on end-of-life outcomes among patients undergoing curative abdominal cancer surgery, suggesting tailored rather than routine involvement.
Read More
PD-ROBOSCORE Validated as a Robust Predictor of Major Morbidity After Pancreaticoduodenectomy: Comparative Insights into Open and Robotic Approaches
Posted inGeneral Surgery news

PD-ROBOSCORE Validated as a Robust Predictor of Major Morbidity After Pancreaticoduodenectomy: Comparative Insights into Open and Robotic Approaches

Posted by By MedXY 10/11/2026
This study externally validates PD-ROBOSCORE as a predictor of major postoperative complications after pancreaticoduodenectomy, demonstrating its comparable performance across open and robotic techniques and highlighting its utility in surgical risk stratification.
Read More
Complete Surgical Resection Enhances Survival in High-Risk Neuroblastoma: Insights from COG ANBL0532 Trial
Posted innews Oncology Pediatrics

Complete Surgical Resection Enhances Survival in High-Risk Neuroblastoma: Insights from COG ANBL0532 Trial

Posted by By MedXY 10/11/2026
Complete resection of the primary tumor significantly improves survival outcomes and reduces local progression without increasing surgical complications in high-risk neuroblastoma patients.
Read More
Pan-European Collaborative Training Elevates Safety and Outcomes in Robotic Pancreatoduodenectomy
Posted inGeneral Surgery news Oncology

Pan-European Collaborative Training Elevates Safety and Outcomes in Robotic Pancreatoduodenectomy

Posted by By MedXY 10/11/2026
A landmark pan-European study confirms that a structured, simulation-based training program enables safe introduction of robotic pancreatoduodenectomy, improving surgeon skills and maintaining patient safety across diverse centers.
Read More

Posts pagination

1 2 3 … 25 Next page
  • Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Under Venetoclax-Based First-Line Therapy
  • High Efficacy and Safety of Glofitamab Plus Polatuzumab-R-CHP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Multicenter Study
  • Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia
  • Optimizing ICU Pharmacist Workload: Impact on Patient Mortality and Medication Management
  • Trajectory of Exacerbations in Biologic-Eligible Severe Asthma: Insights from UK Nationwide Data
Post You Might Like
Posted inHematology-Oncology news
Prognostic Significance of Telomere Length in Chronic Lymphocytic Leukemia Under Venetoclax-Based First-Line Therapy
Posted by By MedXY 10/11/2026
Posted inHematology-Oncology news Oncology
High Efficacy and Safety of Glofitamab Plus Polatuzumab-R-CHP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Multicenter Study
Posted by By MedXY 10/11/2026
Posted inHematology-Oncology news Oncology
Efficacy and Safety of Ziftomenib Combined with Venetoclax and Azacitidine in Relapsed/Refractory NPM1-Mutated Acute Myeloid Leukemia
Posted by By MedXY 10/11/2026
Posted inCritical Care news
Optimizing ICU Pharmacist Workload: Impact on Patient Mortality and Medication Management
Posted by By MedXY 10/11/2026
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification semaglutide SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top